RISK OF KIDNEY DISEASE PROGRESSION AND EFFICACY OF SGLT2 INHIBITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Moura, Filipe [1 ]
Berg, David [1 ]
Bellavia, Andrea [1 ]
Mosenzon, Ofri [1 ]
Dwyer, Jamie [1 ]
Scirica, Benjamin M. [1 ]
Wiviott, Stephen [1 ]
Bhatt, Deepak L. [1 ]
Raz, Itamar [1 ]
Feinberg, Mark William [1 ]
Morrow, David A. [1 ]
Sabatine, Marc Steven [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1493-176
引用
收藏
页码：1808 / 1808
页数：1
相关论文
共 50 条
  • [41] Effect of SGLT2 inhibition on coronary microvascular function in patients with type 2 diabetes
    Suhrs, H. E.
    Bove, K.
    Nilsson, M.
    Zander, M.
    Prescott, E.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2651 - 2651
  • [42] Alleviation of functional iron deficiency by SGLT2 inhibition in patients with type 2 diabetes
    Packer, Milton
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1143 - 1146
  • [43] SGLT2 inhibition in patients with type 2 diabetes and cardiovascular diseases: which are the benefits?
    Diaconu, Camelia
    Salmen, Teodor
    Gaman, Mihnea A.
    Bratu, Ovidiu G.
    Mischianu, Dan
    Marcu, Radu D.
    Suceveanu, Andra I.
    Costache, Raluca S.
    Stoian, Anca Pantea
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2019, 122 (01) : 16 - 21
  • [44] SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
    Kim, Hae Kyung
    Biessels, Geert Jan
    Yu, Min Heui
    Hong, Namki
    Lee, Yong-ho
    Lee, Byung-Wan
    Kang, Eun Seok
    Cha, Bong-Soo
    Lee, Eun Jig
    Lee, Minyoung
    NEUROLOGY, 2024, 103 (08)
  • [45] Efficacy and safety of SGLT2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes
    Nomiyama, Takashi
    Tanabe, Makito
    Murase, Kunitaka
    Motonaga, Ryoko
    Yanase, Toshihiko
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S93 - S93
  • [46] Safety and efficacy of the SGLT2 inhibitor dapagliflozin in older patients with type 2 diabetes
    Fioretto, P.
    de Bruin, T. W.
    Johnsson, E.
    Ptaszynska, A.
    Parikh, S.
    List, J. F.
    DIABETOLOGIA, 2013, 56 : S383 - S383
  • [47] The Clinical Efficacy and Safety of SGLT2 Inhibitors in Japanese Patients with Type 2 Diabetes
    Tosaki, Takahiro
    Kamiya, Hideki
    Kato, Yoshiro
    Kondo, Masaki
    Nakamura, Jiro
    DIABETES, 2015, 64 : A154 - A155
  • [48] The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
    Pitt, Bertram
    Steg, Gabriel
    Leiter, Lawrence A.
    Bhatt, Deepak L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (03) : 561 - 567
  • [49] Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
    Han, Eugene
    Shin, Eugene
    Kim, Gyuri
    Lee, Ji-Yeon
    Lee, Yong-Ho
    Lee, Byung-Wan
    Kang, Eun Seok
    Cha, Bong-Soo
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [50] SGLT2 Inhibitors slow the Progression of chronic Kidney Disease
    不详
    DIABETOLOGE, 2019, 15 (06): : 567 - 567
12345